Jeff is a seasoned pharmaceutical bioprocessing & manufacturing executive with over 25+ years of experience in all aspects of biopharmaceutical development and manufacturing process development in cGMP and non-cGPM settings. Prior to his engagement with GeoVax starting in 2022, he held leadership positions with Emergent Biosolutions and Human Genome Sciences where he led the development and execution of strategies for process development, process characterization and various other manufacturing projects and investigations. Jeff will lead GeoVax’s transition of manufacturing operations to its Contract Development and Manufacturing Organization (CDMO) provider. He received his Bachelor Degree in Chemical Engineering from the Massachusetts Institute of Technology.